Skip to main content

Table 5 Categorical variable information and parameter estimates of the GEE model analysis of adult patients taking AZT based HAART treatment at University of Gondar Specialized Referral Hospital ART clinic from January 2016, to February 2018

From: Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study

Variables

Category

Overall (N = 1920)

Anemia status

P-value

Exp(B)

95% Wald CI for Exp (B)

N (%)

Anemic N = 798 (41.6%)

Non-anemic N = 1122(58.4%)

Sign

AOR

Lower

Upper

Age of ART initiation

< 35 years

660 (34.4%)

278 (42.1%)

382 (57.9%)

0.406

1.202

0.778

1.858

35–45 years

798 (41.6%)

332 (41.6%)

466 (58.4%)

0.549

1.136

0.749

1.723

> 45 years

462 (24.1%)

188 (40.7%)

274 (59.3%)

 –

1

 –

 –

Sex

Male

732 (38.1%)

337 (46.0%)

395 (54.0%)

0.011

1.527

1.102

2.114

Female

1188 (61.9%)

461 (38.8%)

727 (61.2%)

 –

1

 –

 –

Residence

Urban

1422 (74.1%)

561 (39.5%)

861 (60.5%

 –

1

 –

 –

Rural

498 (25.9%)

237 (47.6%)

261 (52.4%)

0.056

1.388

0.992

1.943

Educational status

No

294 (15.3%)

120 (40.8%)

174 (59.2%)

0.750

0.918

0.540

1.559

Primary

528 (27.5%)

230 (43.6%)

298 (56.4%)

0.710

0.914

0.568

1.470

Secondary

786 (40.9%)

314 (39.9%)

472 (60.1%)

0.447

0.847

0.553

1.299

Tertiary

312 (16.2%)

134 (42.9%)

178 (57.1%)

 –

1

 –

 –

WHO clinical stage

Stage I

246 (12.8%)

85 (34.6%)

161 (65.4%)

0.210

0.724

0.437

1.200

Stage II

336 (17.5%)

146 (43.5%)

190 (56.5%)

0.998

1.000

0.674

1.486

Stage III/IV

1338 (69.7%)

567 (42.4%)

771 (57.6%)

 –

1

 –

 –

Baseline CD 4 count

< 200 cell/μl

480 (25.0%)

177 (36.9%)

303 (63.1%)

0.072

0.737

0.528

1.028

> 200 cell/μl

1440 (75.0%)

621(43.1%)

819 (56.9%)

 –

1

 –

 –

BMI at baseline

Under weight

582 (30.3%)

266 (45.7%)

316 (54.3%)

0.430

1.219

0.746

1.991

Normal

1026 (53.4%)

405 (39.5%)

621 (60.5%)

0.665

0.908

0.588

1.403

Over weight

312 (16.2%)

127 (40.7%)

185 (59.3%)

 –

1

 –

 –

Opportunistic infection

No

1668 (86.9%)

693 (41.5%)

975 (58.5%)

0.964

1.011

0.638

1.602

Yes

252 (13.1%)

105 (41.7%)

147 (58.3%)

 –

1

 –

 –

ART regimen type

AZT + 3TC + NVP

1272 (66.2%)

533 (41.9%)

739 (58.1%)

0.046

5.873

1.028

33.550

AZT + 3TC + EFV

570 (29.7%)

234 (41.1%)

336 (58.9%)

0.055

5.566

0.962

32.198

AZT + 3TC + ATV/r

66 (3.4%)

29 (43.9%)

37 (56.1%)

0.062

6.273

0.911

43.181

AZT + 3TC + NVP/r

12 (0.6%)

2 (16.7%)

10 (83.3%)

 –

1

 –

 –

Time of visit (Month)

Base line visit

320 (16.7%)

160 (50.0%)

160 (50.0%)

0.001

1.569

1.196

2.058

6 month

320 (16.7%)

141 (44.1%)

179 (55.9%)

0.132

1.228

0.940

1.603

12 month

320 (16.7%)

114 (35.6%)

206 (64.4%)

0.289

0.856

0.642

1.141

18 month

320 (16.7%)

128 (40.0%)

192 (60.0%)

0.789

1.037

0.794

1.354

24 month

320 (16.7%)

130 (40.6%)

190 (59.4%)

0.618

1.067

0.827

1.376

30 month

320 (16.7%)

125 (39.1%)

195 (60.9%)

 –

1

 –

 –